Fetuin A is another hepatokine that affects insulin sensitivity by inhibition of insulin receptor autophosphorylation (65); in addition, it has shown a good association with NAFLD in a recent systematic review and meta-analysis of 1755 patients and 2010 healthy controls (66). Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.